Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482439 · ClinicalTrials.gov registry record · NA
Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye
A NA study, sponsored by Newsom Eye & Laser Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04482439 is a NA study that has completed, run by Newsom Eye & Laser Center. The registered enrollment target is 35 participants.
The verdict
NCT04482439, a NA study, has completed, sponsored by Newsom Eye & Laser Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective is to assess binocular distance-corrected near (40 cm) visual acuity of patients after uneventful cataract surgery with bilateral implantation of the AcrySof® Vivity Intraocular lens (IOL) when the non-dominant eye is targeted for slight myopia.
Interventions
- DEVICE Vivity Extended Depth of Focus intraocular lens (IOL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2021-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04482439
The ClinicalTrials.gov registry entry for NCT04482439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Newsom Eye & Laser Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vivity Extended Depth of Focus intraocular lens (IOL) is the first listed.
NCT04482439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04482439 about?
NCT04482439 is a clinical study titled "Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye". The objective is to assess binocular distance-corrected near (40 cm) visual acuity of patients after uneventful cataract surgery with bilateral implantation of the AcrySof® Vivity Intraocular lens (IOL) when the non-dominant eye is targeted for slight myopia.
What is the current status of trial NCT04482439?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-07-17. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT04482439?
The interventions under investigation include: Vivity Extended Depth of Focus intraocular lens (IOL) (DEVICE).
Who is sponsoring clinical trial NCT04482439?
This trial is sponsored by Newsom Eye & Laser Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.